LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Syros Pharmaceuticals and Millions of Other Companies

Sign up for full access to Syros Pharmaceuticals information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Key Personnel Change Syros Pharmaceuticals appointed Conley Chee as CEO in December 2023, presenting an opportunity to engage with new leadership and explore potential collaborations or partnerships.

Product Development Syros is developing SY-2101, a novel oral form of arsenic trioxide for the treatment of newly diagnosed APL patients, indicating a focus on innovative treatments that could open avenues for strategic alliances.

Clinical Trial Results The recent launch of clinical data for SY-5609 in patients with various cancers demonstrates Syros' commitment to advancing new standards of care, providing an opportunity to engage healthcare professionals with promising treatment outcomes.

Market Expansion With a focus on hematologic malignancies, Syros is well-positioned to tap into the growing market for treatments targeting blood disorders, presenting an opportunity for partnerships or distribution agreements in this specialized field.

Competitive Positioning Amid partnerships like the terminated deal with Pfizer and development efforts for beta thalassemia treatments, exploring synergies with Syros could offer a chance to address unmet needs and strengthen competitive positioning in the pharmaceutical market.

Similar companies to Syros Pharmaceuticals

✕

Access Insights for Syros Pharmaceuticals and Millions of Other Companies

Sign up for full access to Syros Pharmaceuticals information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Syros Pharmaceuticals Tech Stack

Syros Pharmaceuticals uses 8 technology products and services including Google Analytics, Squarespace, Typekit, and more. Explore Syros Pharmaceuticals's tech stack below.

  • Google Analytics
    Analytics
  • Squarespace
    Content Management System
  • Typekit
    Font Scripts
  • Google Font API
    Font Scripts
  • Preact
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Apache
    Web Servers
  • Linkedin
    Widgets

Media & News

Syros Pharmaceuticals's Email Address Formats

Syros Pharmaceuticals uses at least 1 format(s):
Syros Pharmaceuticals Email FormatsExamplePercentage
FLast@syros.comJDoe@syros.com
95%
LastFirst@syros.comDoeJohn@syros.com
2%
Last.First@syros.comDoe.John@syros.com
2%
FirstLast@syros.comJohnDoe@syros.com
1%

Frequently Asked Questions

Where is Syros Pharmaceuticals's headquarters located?

Minus sign iconPlus sign iconSyros Pharmaceuticals's main headquarters is located at 35 CambridgePark Drive 4th Floor Cambridge , MA 02140 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Syros Pharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact Syros Pharmaceuticals's main corporate office by phone at
✕

Access Insights for Syros Pharmaceuticals and Millions of Other Companies

Sign up for full access to Syros Pharmaceuticals information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-617-744-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Syros Pharmaceuticals's stock symbol?

Minus sign iconPlus sign iconSyros Pharmaceuticals is a publicly traded company; the company's stock symbol is SYRS.

What is Syros Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconSyros Pharmaceuticals's official website is syros.com and has social profiles on LinkedIn.

How much revenue does Syros Pharmaceuticals generate?

Minus sign iconPlus sign icon As of August 2024, Syros Pharmaceuticals's annual revenue reached $35M.

What is Syros Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconSyros Pharmaceuticals's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Syros Pharmaceuticals have currently?

Minus sign iconPlus sign iconAs of August 2024, Syros Pharmaceuticals has approximately 98 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: C. C.COO: K. K.Chief Financial Officer: J. H.. Explore Syros Pharmaceuticals's employee directory with LeadIQ.

What industry does Syros Pharmaceuticals belong to?

Minus sign iconPlus sign iconSyros Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Syros Pharmaceuticals use?

Minus sign iconPlus sign iconSyros Pharmaceuticals's tech stack includes Google AnalyticsSquarespaceTypekitGoogle Font APIPreactWebpackApacheLinkedin.

What is Syros Pharmaceuticals's email format?

Minus sign iconPlus sign iconSyros Pharmaceuticals's email format typically follows the pattern of . Find more Syros Pharmaceuticals email formats with LeadIQ.

How much funding has Syros Pharmaceuticals raised to date?

Minus sign iconPlus sign icon As of August 2024, Syros Pharmaceuticals has raised $45M in funding. The last funding round occurred on Dec 19, 2023 for $45M.

When was Syros Pharmaceuticals founded?

Minus sign iconPlus sign iconSyros Pharmaceuticals was founded in 2012.
Syros Pharmaceuticals

Syros Pharmaceuticals

Pharmaceutical ManufacturingMassachusetts, United States51-200 Employees

Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome with RARA gene overexpression. For more information, visit www.syros.com and follow us on X (@SyrosPharma) and LinkedIn.

✕

Access Insights for Syros Pharmaceuticals and Millions of Other Companies

Sign up for full access to Syros Pharmaceuticals information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
35 CambridgePark Drive 4th Floor Cambridge , MA 02140 US
Phone number
✕

Access Insights for Syros Pharmaceuticals and Millions of Other Companies

Sign up for full access to Syros Pharmaceuticals information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-617-744-****
Website
syros.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
SYRS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $45M

    Syros Pharmaceuticals has raised a total of $45M of funding over 11 rounds. Their latest funding round was raised on Dec 19, 2023 in the amount of $45M.

  • $10M$50M

    Syros Pharmaceuticals's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $45M

    Syros Pharmaceuticals has raised a total of $45M of funding over 11 rounds. Their latest funding round was raised on Dec 19, 2023 in the amount of $45M.

  • $10M$50M

    Syros Pharmaceuticals's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Syros Pharmaceuticals and Millions of Other Companies

Sign up for full access to Syros Pharmaceuticals information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.